Remember, biosimilars are like the original drug. They have been tested to make sure they work in the same way. Your doctor or pharmacist can answer any specific questions you have. They will give you ...

Again using generics as an example, patients initially were skeptical as they were concerned that these products were lesser than the branded drugs they may have already been taking. Biosimilars ...

for example, an animal cell or microorganism. The first biological medicine to be approved for use in the European Union for a particular condition is called the biological reference medicine. A ...

For example, CVS could absorb a portion of a biosimilar manufacturer’s profit margin, Fein wrote in an article posted on the Drug Channels website. Other examples include establishing ...

To move this biosimilar into clinical trials, though, industrial scientists would need more thorough testing, including toxicology studies. As this example shows, a long path lies between any ...

Note that the “proprietary name” of a biosimilar product is a brand name determined by the sponsor. The fictitious example provided in the 2023 Draft Guidance is “NEXSYMEO.” The “proper ...

For example, when Biocon and Viatris launched their interchangeable insulin biosimilar, Semglee, with two different prices, many payers didn’t even offer the lower-priced version. Meanwhile ...

Hadlima was approved as a biosimilar to Humira in 2019 ... health care system through this collaboration, which is a great example of industry and public sector working together,” Ali added.

But there are key players who are not on board with biosimilars. And their reticence could hinder the uptake of these lower-cost knockoffs. For example, a study last month showed (PDF) that ...